<DOC>
	<DOCNO>NCT02479620</DOCNO>
	<brief_summary>This prospective , multi-center , randomize pilot study document effect adventitial delivery dexamethasone atherectomy-based revascularizations lesion knee symptomatic patient critical limb ischemia ( CLI ) .</brief_summary>
	<brief_title>Lower-Limb Adventitial Infusion DexaMethasone Via Bullfrog Reduce Occurrence Restenosis After Atherectomy ( ATX ) -Based Revascularization</brief_title>
	<detailed_description>This prospective , multi-center , randomize pilot study document effect adventitial delivery dexamethasone atherectomy-based revascularizations lesion knee symptomatic patient critical limb ischemia ( CLI ) . Up 120 patient ( 60 treatment 60 control ) , include 20 Rutherford 6 patient ( 10 treatment 10 control ) 30 site United States Europe . This study ass safety effectiveness Bullfrog Micro-Infusion Device adventitial deposition dexamethasone reduce inflammation restenosis patient clinical evidence chronic critical limb ischemia angiographically significant lesion infrapopliteal crural vessel .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Screening Criteria : Age ≥18 year Patient patient 's legal representative inform nature study , agree participate sign IRB/EC approve consent form Female patient childbearing potential negative pregnancy test ≤7 day procedure willing use reliable method birth control duration study participation Patient document chronic Critical Limb Ischemia ( CLI ) target limb popliteal artery ankle joint prior study procedure Rutherford Category 4 , 5 6 Life expectancy &gt; 1 year Investigator 's opinion Angiographic Criteria : Successful revascularization TL le 30 % residual stenosis , runoff foot direct inline flow foot wind Reference vessel ( ) diameter ≥2 mm Single multiple atherosclerotic lesion ≥70 % least one infrapopliteal crural target vessel include tibioperoneal trunk total 30 cm length ( great 5 cm length contiguous intervene normal artery ) , possible extension popliteal artery distal center knee joint space ( P3 segment ) Screening Criteria : Patient unwilling unlikely comply visit schedule Planned major index limb amputation Active foot infection ; however , osteomyelitis toe mild cellulitis around perimeter gangrene small ulcer exclusion , osteomyelitis metatarsal proximal region would exclusionary Inability receive study medication Estimated glomerular filtration rate ( eGFR ) less 30 mL/min , except patient end stage renal disease chronic hemodialysis Stage 3 ( per SVS WIfI classification ) bad heel ulcer heel ulcer determine primarily neuropathic nature Angiographic/Procedural Criteria : Hemodynamically significant inflow lesion ( ≥50 % DS ) occlusion ipsilateral iliac , SFA , popliteal artery failure successfully treat obtain &lt; 30 % residual stenosis Target lesion length &gt; 25 cm measure proximal normal vessel distal normal vessel Total length lesion treat case ( include target lesion , inflow lesion , nontarget lesion ) &gt; 25 cm Lesions revascularized index case untreated Bullfrog Use alternative therapy , e.g . radiation therapy , part index lesion treatment , use drug eluting stent ( DES ) drugeluting balloon/drugcoated balloon ( DEB/DCB ) treatment infrainguinal lesion study procedure initial sixmonth follow period Previously implant stent TL ( ) Aneurysm target vessel Acute thrombus target limb Failure cross TL guide wire ; however , subintimal wire crossing allow Heavy eccentric concentric calcification index lesion , judgment investigator would prevent penetration MicroInfusion Device needle vessel wall</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>